Literature DB >> 16707637

Current concepts in diabetic microvascular dysfunction.

Javier La Fontaine1, Lawrence B Harkless, Christian E Davis, Marque A Allen, Paula K Shireman.   

Abstract

Microvascular dysfunction is an important component of the pathologic processes that occur in diabetic foot disease. The endothelial abnormalities observed in patients with diabetes mellitus are poorly understood, and evidence suggests that endothelial dysfunction could be involved in the pathogenesis of diabetic macroangiopathy and microangiopathy. With the advent of insulin replacement in the early 1900s and increased efforts toward metabolic control of diabetes, long-term complications of this disease have become apparent. These late-term complications are primarily disorders of the vascular system. This article reviews the process of microvascular dysfunction and how it may relate to the pathogenesis of diabetic foot problems.

Entities:  

Mesh:

Year:  2006        PMID: 16707637     DOI: 10.7547/0960245

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  7 in total

1.  A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus.

Authors:  Maria Galán; Modar Kassan; Soo-Kyoung Choi; Megan Partyka; Mohamed Trebak; Daniel Henrion; Khalid Matrougui
Journal:  Hypertension       Date:  2012-06-04       Impact factor: 10.190

Review 2.  Genetic and epigenetic events in diabetic wound healing.

Authors:  Haloom Rafehi; Assam El-Osta; Tom C Karagiannis
Journal:  Int Wound J       Date:  2010-12-16       Impact factor: 3.315

Review 3.  Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing.

Authors:  Zhao-Jun Liu; Omaida C Velazquez
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

4.  Effects of spinal anesthesia on the peripheral and deep core temperature in elderly diabetic patients undergoing urological surgery.

Authors:  Takashi Suto; Tomonori Takazawa; Koichi Nishikawa; Fumio Goto
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

5.  Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis.

Authors:  Hao Zhou; Ying Zhang; Shunying Hu; Chen Shi; Pingjun Zhu; Qiang Ma; Qinhua Jin; Feng Cao; Feng Tian; Yundai Chen
Journal:  J Pineal Res       Date:  2017-04-27       Impact factor: 13.007

6.  Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study.

Authors:  Marco Bagnati; Chiara Puricelli; Giulia Bauce; Matteo Basile; Barbara Grigollo; Flavia Prodam; Umberto Dianzani; Giorgio Bellomo; Roberta Rolla
Journal:  Biomed Res Int       Date:  2021-12-02       Impact factor: 3.411

7.  Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism.

Authors:  Dongjuan Wang; Peng Luo; Yabin Wang; Weijie Li; Chen Wang; Dongdong Sun; Rongqing Zhang; Tao Su; Xiaowei Ma; Chao Zeng; Haichang Wang; Jun Ren; Feng Cao
Journal:  Diabetes       Date:  2013-01-30       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.